PANEL RECOMMENDS NEW DRUG TO TREAT MULTIPLE SCLEROSIS
A Federal advisory committee today recommended approval of a new drug to treat multiple sclerosis. The drug is the first shown to be effective against the neurological disease, although hundreds have been tried over the decades. In a 7-to-2 vote, the committee found that the drug, Betaseron, made by the Chiron Corporation and Berlex Labs, a subsidiary of Schering A.G. of Germany, was safe and effective in treating the disease. The drug is not a cure, but a new study presented to the committee indicated that it can slow the otherwise relentless course of the disease.
